Research progress of endoscopic treatment for malignant biliary obstruction

doi:10.3877/cma.j.issn.1674-0793.2017.01.015

Abstract

Abstract:

Malignant biliary obstruction is caused by biliary or other metastatic malignant tumors, mainly with obstruction jaundice, bile duct dilatation, and liver damage as its clinical presentation. In later period, patients are characterized with deterioration of liver function, easily combined with acute obstructive and suppurative cholangitis and kidney function exhaustion. Most of the patients are late for medical treatment and lose the chance of operation. The endoscopic retrograde cholangiopancreatography(ERCP), a palliative minimally invasive treatment, has endoscopic nasobiliary drainage and stents, intraductal radiofrequency, endoscopic photodynamic therapy, and been carried out widely. Compared with percutaneous transhepatic catheter drainage (PTCD), ERCP has advantages of less pain and simpler operation. In this paper, the main methods and research progress of ERCP in relieving malignant biliary obstruction are reviewed.

Key words: Cholestasis, Cholangiopancreatography, endoscopic retrograde, Biliary obstruction, Stent

Yue Li, Nan He, Liangqi Cao. Research progress of endoscopic treatment for malignant biliary obstruction[J]. Chinese Archives of General Surgery(Electronic Edition), 2017, 11(01): 56-60.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhptwkxwx.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0793.2017.01.015

https://zhptwkxwx.cma-cmc.com.cn/EN/Y2017/V11/I01/56

References 42

[1]	Boulay BR,Birg A. Malignant biliary obstruction: From palliation to treatment[J]. World J Gastrointest Oncol, 2016, 8(6): 498-508.
[2]	Inamdar S,Slattery E,Bhalla R, et al. Comparison of adverse events for endoscopic vs percutaneous biliary drainage in the treatment of malignant biliary tract obstruction in an Inpatient National Cohort[J]. JAMA Oncol, 2016, 2(1): 112-117.
[3]	Kumar R,Sharma BC,Singh J, et al. Endoscopic biliary drainage for severe acute cholangitis in biliary obstruction as a result of malignant and benign diseases[J]. J Gastroenterol Hepatol, 2004, 19(9): 994-997.
[4]	Sasahira N,Hamada T,Togawa O, et al. Multicenter study of endoscopic preoperative biliary drainage for malignant distal biliary obstruction[J]. World J Gastroenterol, 2016, 22(14): 3793-3802.
[5]	Hu B,Zhou D,Gong B. The evaluation of endoscopic biliary drainage for 288 patients with malignant hilar obstruction[J]. Zhonghua Wai Ke Za Zhi, 1997, 35(2): 73-76.
[6]	Sugiyama H,Tsuyuguchi T,Sakai Y et al. Preoperative drainage for distal biliary obstruction: endoscopic stenting or nasobiliary drainage[J]. Hepatogastroenterology, 2013, 60(122): 231-234.
[7]	Rustagi T,Jamidar PA. Intraductal radiofrequency ablation for management of malignant biliary obstruction[J]. Dig Dis Sci, 2014, 59(11): 2635-2641.
[8]	Alis H,Sengoz C,Gonenc M, et al. Endobiliary radiofrequency ablation for malignant biliary obstruction[J]. Hepatobiliary Pancreat Dis Int, 2013, 12(4): 423-427.
[9]	Zoepf T,Jakobs R,Arnold JC, et al. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy[J]. Am J Gastroenterol, 2005, 100(11): 2426-2430.
[10]	Dolak W,Schreiber F,Schwaighofer H, et al. Endoscopic radiofrequency ablation for malignant biliary obstruction: a nationwide retrospective study of 84 consecutive applications[J]. Surg Endosc, 2014, 28(3): 854-860.
[11]	Sharaiha RZ,Sethi A,Weaver KR, et al. Impact of radiofrequency ablation on malignant biliary strictures: results of a collaborative registry[J]. Dig Dis Sci, 2015, 60(7): 2164-2169.
[12]	Mensah ET,Martin J,Topazian M. Radiofrequency ablation for biliary malignancies[J]. Curr Opin Gastroenterol, 2016, 32(3): 238-243.
[13]	Wilcox CM,Kim H,Seay T, et al. Choice of plastic or metal stent for patients with jaundice with pancreaticobiliary malignancy using simple clinical tools: a prospective evaluation[J]. BMJ Open Gastro, 2015, 2(1): e000014.
[14]	Elwir S,Sharzehi K,Veith J, et al. Biliary stenting in patients with malignant biliary obstruction: comparison of double layer, plastic and metal stents[J]. Dig Dis Sci, 2013, 58(7): 2088-2092.
[15]	Lübbert C,Wendt K,Feisthammel J, et al. Epidemiology and resistance patterns of bacterial and Fungal colonization of biliary plastic stents: a prospective cohort study[J]. Published, 2016, 11(5): e0155479.
[16]	Hamada T,Isayama H,Nakai Y, et al. Tips and troubleshooting for transpapillary metal stenting for distal malignant biliary obstruction[J]. J Hepatobiliary Pancreat Sci, 2014, 21(3): E12-18.
[17]	Naitoh I,Nakazawa T,Ban T, et al. 8-mm versus 10-mm diameter self-expandable metallic stent in bilateral endoscopic stent-in-stent deployment for malignant hilar biliary obstruction[J]. J Hepatobiliary Pancreat Sci, 2015, 22(5): 396-401.
[18]	Yamamoto R,Takahashi M,Osafune Y, et al. Comparison of endoscopic stenting for malignant biliary obstruction: a single-center study[J]. World J Gastrointest Endosc, 2015, 7(9): 889-894.
[19]	Darcózi T,Bor R,Fábián A, et al. Cost-effectiveness trial of self-expandable metal stents and plastic biliary stents in malignant biliary obstruction[J]. Orvosi Hetilap, 2016, 157(7): 268-274.
[20]	Chung KH,Lee SH,Park JM, et al. Self-expandable metallic stents vs. plastic stents for endoscopic biliary drainage in hepatocellular carcinoma[J]. Endoscopy, 2015, 47(6): 508-516.
[21]	Zorrón Pu L,de Moura EG,Bernardo WM, et al. Endoscopic stenting for inoperable malignant biliary obstruction: A systematic review and meta-analysis[J]. World J Gastroenterol, 2015, 21(47): 13374-13385.
[22]	Hong W,Sun X,Zhu Q. Endoscopic stenting for malignant hilar biliary obstruction: should it be metal or plastic and unilateral or bilateral[J]. Eur J Gastroenterol Hepatol, 2013, 25(9): 1105-1112.
[23]	Hong WD,Chen XW,Wu WZ, et al. Metal versus plastic stents for malignant biliary obstruction: an update meta-analysis[J]. Clin Res Hepatol Gastroenterol, 2013, 37(5): 496-500.
[24]	Lee BS,Ryu JK,Jang DK, et al. Reintervention for occluded metal stent in malignant bile duct obstruction: a prospective randomized trial comparing covered and uncovered metal stent[J]. J Gastroenterol Hepatol, 2016, 5,31.
[25]	Barkun AN,Adam V,Martel M, et al. Partially covered self-expandable metal stents versus polyethylene stents for malignant biliary obstruction: a cost-effectiveness analysis[J]. Can J Gastroenterol Hepatol, 2015, 29(7): 377-383.
[26]	Kahaleh M,Talreja JP,Loren DE, et al. Evaluation of a fully covered self-expanding metal stent with flared ends in malignant biliary obstruction: a multicenter study[J]. J Clin Gastroenterol, 2013, 47(10): 96-100.
[27]	Lee JH,Krishna SG,Singh A, et al. Comparison of the utility of covered metal stents versus uncovered metal stents in the management of malignant biliaray strictures in 749 patients[J]. Gastrointest Endosc, 2013, 78(2): 312-324.
[28]	Park JS,Jeong S,Lee DH, et al. A double-layered covered biliary metal stent for the management of unresectable malignant biliary obstruction: A multicenter feasibility study[J]. Gut Liver, 2016, 5,16.
[29]	Shatzel J,Kim J,Sampath K. Drug eluting biliary stents to decrease stent failure rates: A review of the literature[J]. World J Gastrointest Endosc, 2016, 8(2): 77-85.
[30]	Jang SI,Kim JH,You JW. Efficacy of a metallic stent covered with a paclitaxel-incorporated membrane versus a covered metal stent for malignant biliary obstruction: a prospective comparative study[J]. Dig Dis Sci, 2013, 58(3): 865-871.
[31]	Suk KT,Kim JW,Kim HS. Human application of a metallic stent covered with a paclitaxel-incorporated membrane for malignant biliary obstruction: multicenter pilot study[J]. Gastrointest Endosc, 2007, 66(4): 798-803.
[32]	Bertani H,Frazzoni M,Mangiafico S, et al. Cholangiocarcinoma and malignant bile duct obstruction: A review of last decades advances in therapeutic endoscopy[J]. World J Gastrointest Endosc, 2015, 7(6): 582-592.
[33]	Choi JM,Kim JH,Kim SS, et al. A comparative study on the efficacy of covered metal stent and plastic stent in unresectable malignant biliary obstruction[J]. Clin Endosc, 2012, 45(1): 78-83.
[34]	Singh V. Decompression of malignant biliary obstruction after failed ERCP: to EUSBD and not to PTBD[J]. Dig Dis Sci, 2015, 60(2): 288-289.
[35]	Fabbri C,Luigiano C,Fuccio L, et al. EUS-guided biliary drainage with placement of a new partially covered biliary stent for palliation of malignant biliary obstruction: a case series[J]. Endoscopy, 2011, 43(5): 438-441.
[36]	Nguyen-Tang T,Binmoeller KF,Sanchez-Yague A, et al. Endoscopic ultrasound (EUS)-guided transhepatic anterograde self-expandable metal stent (SEMS) placement across malignant biliary obstruction[J]. Endoscopy, 2010, 42(3): 232-236.
[37]	Hucl T. Malignant biliary obstruction[J]. Cas Lek Cesk, 2016, 155(1): 30-37.
[38]	Beer F,Wiedmann M,Tannapfel A, et al. Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival[J]. Hepatology, 2000, 31(2): 291-298.
[39]	Pereira SP,Ayaru L,Rogowska A, et al. Photodynamic therapy of malignant biliary strictures using meso-tetrahydroxyphenylchlorin[J]. Eur J Gastroenterol Hepatol, 2007, 19(6): 479-485.
[40]	Matull WR,Dhar DK,Ayaru L, et al. R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer[J]. Liver Int, 2011, 31(1): 99-107.
[41]	刘俊杰,薛平. 晚期胆管癌姑息性切除、光动力治疗及支架引流疗效的Meta分析[J/CD]. 中华普通外科学文献（电子版）, 2015, 9(3): 242-248.
[42]	Ortner ME,Caca K,Berr F, et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study[J]. Gastroenterology, 2003, 125(5): 1355-1363.

Please choose a citation manager

Content to export